Raypal Medical, a subsidiary of the Compal Group, a leading multi-billion-dollar corporation, is at the forefront of cellular therapy. With years of dedicated service in immunotherapy for cancer patients, we are now expanding our expertise to include regenerative medicine, specifically focusing on Mesenchymal Stem Cells and exosomes. Our extensive experience in cell cultivation and expansion positions us as a trusted leader in the exosome field, where we harness the power of these innovative therapies to promote healing and regeneration. At Raypal, we are committed to advancing healthcare through cutting-edge solutions that make a difference in patients' lives.
Company Details
- Employees
- 3
- Founded
- 2016
- Address
- No. 581-1, Ruiguang Rd., Neihu District,, Taipei City,taiwan 11492,taiwan, Province Of China
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.raypal-bio.com/
- HQ
- Taipei City, Taiwan
Raypal Biomedical Questions
Raypal Biomedical's website is https://www.raypal-bio.com/
Raypal Biomedical's LinkedIn profile is https://tw.linkedin.com/company/raypal-biomedical
Raypal Biomedical has
3 employees.
View email and phone details for 3
employees at Raypal Biomedical.
Raypal Biomedical's industry is
Biotechnology Research
Raypal Biomedical's top competitors are
Ap Biosciences, Inc.,
Aepromed Innovation Corp.,ltd.,
Incannex Healthcare Inc,
Монос Эмийн Үйлдвэр / Monospharma /,
Luxgen Motor,
Motor Image - Subaru,
Plexbio Co., Ltd.,
Leon Biotech. Co., Ltd,
Neuclone,
Hipposcreen Neurotech Corp..
Raypal Biomedical's categories are Biotechnology Research
Raypal Biomedical's founding year is 2016
